-
Production Resumes at Troubled Abbott Baby Formula Factory
Abbott Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage.
-
Baby Formula Plant Stops EleCare Production After Storm Causes Flooding
Abbott Laboratories said it stopped production of one of its specialty formula products, EleCare, after parts of its plant in Michigan was flooded.
-
Abbott Restarts Baby Formula Plant Linked to Contamination
Abbott says it’s restarted production at the Michigan factory that’s tied to the ongoing baby formula shortage. The plant has been closed since February due to contamination, and that’s led to nationwide supply problems for formulas needed to feed infants. The reopening isn’t expected to have an immediate affect on availability. Abbott says it’ll prioritize production of its specialty formulas...
-
Biden Details Efforts to Resolve Baby Formula Crisis
President Joe Biden delivered remarks Wednesday on federal efforts to address the national baby formula shortage, including a third delivery of baby formula through Operation Fly Formula. “I’m going to make sure that families in every part of the country can get the formula they need.”
-
Biden Rolls Out 2-Part Strategy to Address Formula Shortages
The Biden Administration announced Wednesday that it is rolling out a two-part strategy to address the nationwide infant formula shortage, including an invocation of the Defense Production Act.
-
Abbott, FDA Reach Deal to Reopen Baby Formula Plant Amid Shortage
The FDA announced steps Monday to ease a nationwide shortage of baby formula, including reopening the largest domestic manufacturing plant and increasing imports from overseas.
-
Biden Rolls Out Plan to Alleviate Baby Formula Shortage
President Joe Biden spoke Friday to confirm steps being taken by the FDA and HHS to alleviate shortages in baby formula, including loosening the brand eligibility for WIC programs and a platform to help parents find specific products.
-
FDA to Allow Closed Abbott Plant to Release Baby Formula Supply Amid Shortage
After ordering Abbott’s Michigan plant to close due to contamination concerns following a nationwide recall of baby formula, the FDA said the company can release some specialty formulas “on a case-by-case basis”
-
CVS, Walgreens Limit Baby Formula Sales Amid Supply Shortages
Ongoing supply-chain issues were exacerbated by a massive nationwide recall of baby formula produced at an Abbott Labs facility in Sturgis, Michigan.
-
Retailers Set Purchase Limits Amid Baby Formula Shortage
Retailers CVS and Walgreens announce they are setting limits on the number of baby formula products customers can purchase as the U.S. faces an ongoing baby formula shortage.
-
Yale Professor Behind Corporate ‘Naughty-Or-Nice List' Lauds U.S. Brands' Decision to Pause Russia Business
McDonald’s, Starbucks, Coca-Cola and Pepsi suspended business in Russia over the war in Ukraine.
-
Some Trump Allies Want Him to Pull His Endorsement of Texas Gov. Greg Abbott Ahead of GOP Primary
Donald Trump’s team has heard from allies who are trying to encourage the former president to withdraw his support for Texas Gov. Greg Abbott.
-
How the U.S. Is Trying to Fix Its At-Home Covid Testing Problem
One tool was noticeably absent from the U.S.’s Covid-19 pandemic-fighting arsenal: at-home rapid tests. Despite their short supply, the Biden administration has made it clear that the tests will be critical when it comes to reopening the U.S. economy. The White House is taking a number of steps to bolster supply and lower costs for the over-the-counter tests. The...
-
Markets Are Expected to Remain on Edge as the Fed Meets in the Week Ahead
The Federal Reserve’s meeting trumps everything else for markets in the week ahead, as investors await any new clues on its plans to raise interest rates.
-
Companies Raise Perks to Repay Employees' Student Loans
Employers are looking for creative ways to attract skilled talent. One approach: student loan assistance programs to help workers pay off college debt.
-
Drugstores Struggle to Keep Covid At-Home Tests in Stock as Omicron Rages Across U.S.
There is a “tsunami of demand” for Covid tests as businesses prepare for the Biden’s administration vaccine and testing mandates and omicron surges.
-
We're Trimming Two of Our Holdings That Are Trading Near Their Highs
We are making a couple of trims this afternoon in stocks that are trading at or near their all-time highs.
-
Investing Club: What Jim Cramer Is Watching Wednesday — A Good Call on This Retail Stock
Jim’s latest thoughts on omicron and the big analyst calls of the morning.
-
Walgreens, CVS Limit How Many At-Home Covid Tests Customers Can Buy Due to Demand Surge on Omicron Fears
Walgreens said the “unprecedented increase in demand” for rapid at-home Covid tests started after Thanksgiving and have continued through the week of Christmas.
-
Don't Panic, and Start Working on Your Buy List
Today’s decline makes for a good time to brush off the list of companies that did well in the height of the pandemic last year.